C. Baudet et al., 1,25-DIHYDROXYVITAMIN-D3 INDUCES PROGRAMMED CELL-DEATH IN A RAT GLIOMA CELL-LINE, Journal of neuroscience research, 46(5), 1996, pp. 540-550
1,25-Dihydroxyvitamin D3 (1,25(OH)(2)D-3), a seco-steroid hormone with
potential antitumoral activities, has been recently reporterd to exer
t cytotoxic effects on C6 glioma cells. However, the molecular mechani
sms which trigger this cell death remain unknown. We show here that th
is 1,25(OH)(2)D-3-induced cell death is dependent upon protein synthes
is and is accompanied by the expression off c-myc, p53, and gadd45 gen
es, Two other genes, coding for interleukin-6 and vaso-endothelial gro
wth factor, dare also up-regulated after addition of 1,25(OH)(2)D-3, T
his programmed cell death can be suppressed when cells are treated wit
h forskolin, a drug which increases intracellular cAMP concentration,
or with genistein, an inhibitor of tyrosine protein kinases. However,
in spite of the demonstration of fragmented DNA in 1,25(OH)(2)D-3-trea
ted cells, the C6.9 cells used in this study do not show the classical
morphological features of apoptosis, These results provide the first
evidence for the existence of a programmed cell death triggered by 1,2
5(OH)(2)D-3 in glioma cells and may provide a basis for the developmen
t off new therapeutic strategies, In addition, these data also suggest
that the treatment of C6.9 cells with 1,25(OH)(2)D-3 may be a useful
model to study the molecular mechanisms involved inn the programmed ce
ll death of a cell of glial origin. (C) 1996 Wiley-Liss, Inc.